10.3 USD
-0.02 (-0.19%)
10.449 USD
+0.15 (+1.45%)
Overall DCTH gets a fundamental rating of 6 out of 10. We evaluated DCTH against 186 industry peers in the Health Care Equipment & Supplies industry. While DCTH has a great health rating, its profitability is only average at the moment. DCTH is not overvalued while it is showing excellent growth. This is an interesting combination.
1. Profitability
1.1 Basic Checks
DCTH had positive earnings in the past year.
In the past year DCTH had a positive cash flow from operations.
In the past 5 years DCTH always reported negative net income.
DCTH had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
DCTH has a Return On Assets of 0.96%. This is in the better half of the industry: DCTH outperforms 74.19% of its industry peers.
With a decent Return On Equity value of 1.04%, DCTH is doing good in the industry, outperforming 74.19% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 4.00%, DCTH is in the better half of the industry, outperforming 73.66% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.96% | ||
| ROE | 1.04% | ||
| ROIC | 4% |
ROA(3y)-120.78%
ROA(5y)-101.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of DCTH (1.50%) is better than 74.73% of its industry peers.
With a decent Operating Margin value of 7.39%, DCTH is doing good in the industry, outperforming 73.66% of the companies in the same industry.
DCTH has a Gross Margin of 86.29%. This is amongst the best in the industry. DCTH outperforms 95.16% of its industry peers.
DCTH's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.39% | ||
| PM (TTM) | 1.5% | ||
| GM | 86.29% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.01%
GM growth 5Y8.9%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DCTH is destroying value.
DCTH has more shares outstanding than it did 1 year ago.
The number of shares outstanding for DCTH has been increased compared to 5 years ago.
DCTH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 19.04 indicates that DCTH is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 19.04, DCTH belongs to the top of the industry, outperforming 94.62% of the companies in the same industry.
DCTH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 19.04 |
ROIC/WACC0.45
WACC8.92%
2.3 Liquidity
A Current Ratio of 15.06 indicates that DCTH has no problem at all paying its short term obligations.
With an excellent Current ratio value of 15.06, DCTH belongs to the best of the industry, outperforming 98.39% of the companies in the same industry.
DCTH has a Quick Ratio of 13.71. This indicates that DCTH is financially healthy and has no problem in meeting its short term obligations.
DCTH has a Quick ratio of 13.71. This is amongst the best in the industry. DCTH outperforms 98.39% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 15.06 | ||
| Quick Ratio | 13.71 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 100.74% over the past year.
The Revenue has grown by 251.54% in the past year. This is a very strong growth!
The Revenue has been growing by 88.10% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)100.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
Revenue 1Y (TTM)251.54%
Revenue growth 3Y118.63%
Revenue growth 5Y88.1%
Sales Q2Q%83.6%
3.2 Future
Based on estimates for the next years, DCTH will show a very strong growth in Earnings Per Share. The EPS will grow by 30.41% on average per year.
Based on estimates for the next years, DCTH will show a very strong growth in Revenue. The Revenue will grow by 43.08% on average per year.
EPS Next Y104.16%
EPS Next 2Y54.49%
EPS Next 3Y40.77%
EPS Next 5Y30.41%
Revenue Next Year135.53%
Revenue Next 2Y81.08%
Revenue Next 3Y61.94%
Revenue Next 5Y43.08%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 1030.00, which means the current valuation is very expensive for DCTH.
DCTH's Price/Earnings ratio is a bit cheaper when compared to the industry. DCTH is cheaper than 64.52% of the companies in the same industry.
When comparing the Price/Earnings ratio of DCTH to the average of the S&P500 Index (26.92), we can say DCTH is valued expensively.
The Price/Forward Earnings ratio is 27.17, which means the current valuation is very expensive for DCTH.
Based on the Price/Forward Earnings ratio, DCTH is valued a bit cheaper than the industry average as 73.66% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of DCTH to the average of the S&P500 Index (23.46), we can say DCTH is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 1030 | ||
| Fwd PE | 27.17 |
4.2 Price Multiples
69.35% of the companies in the same industry are more expensive than DCTH, based on the Enterprise Value to EBITDA ratio.
DCTH's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. DCTH is cheaper than 79.03% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.22 | ||
| EV/EBITDA | 37.45 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DCTH does not grow enough to justify the current Price/Earnings ratio.
DCTH's earnings are expected to grow with 40.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)9.89
PEG (5Y)N/A
EPS Next 2Y54.49%
EPS Next 3Y40.77%
5. Dividend
5.1 Amount
No dividends for DCTH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
10.3
-0.02 (-0.19%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners51.08%
Inst Owner Change-1.9%
Ins Owners2.74%
Ins Owner Change0.48%
Market Cap363.69M
Revenue(TTM)79.60M
Net Income(TTM)1.20M
Analysts84.62
Price Target23.61 (129.22%)
Short Float %12.62%
Short Ratio4.53
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)86.27%
Min EPS beat(2)-1.96%
Max EPS beat(2)174.51%
EPS beat(4)2
Avg EPS beat(4)-54.93%
Min EPS beat(4)-488.34%
Max EPS beat(4)174.51%
EPS beat(8)5
Avg EPS beat(8)-13.29%
EPS beat(12)5
Avg EPS beat(12)-23.68%
EPS beat(16)7
Avg EPS beat(16)-17.29%
Revenue beat(2)1
Avg Revenue beat(2)0.07%
Min Revenue beat(2)-3.57%
Max Revenue beat(2)3.72%
Revenue beat(4)3
Avg Revenue beat(4)5.71%
Min Revenue beat(4)-3.57%
Max Revenue beat(4)15.26%
Revenue beat(8)6
Avg Revenue beat(8)14%
Revenue beat(12)6
Avg Revenue beat(12)0.03%
Revenue beat(16)10
Avg Revenue beat(16)26.29%
PT rev (1m)0%
PT rev (3m)-8.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-265.52%
EPS NY rev (1m)7.7%
EPS NY rev (3m)-15.15%
Revenue NQ rev (1m)-0.52%
Revenue NQ rev (3m)-25.24%
Revenue NY rev (1m)-1.45%
Revenue NY rev (3m)-10.62%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 1030 | ||
| Fwd PE | 27.17 | ||
| P/S | 4.57 | ||
| P/FCF | 30.22 | ||
| P/OCF | 27.42 | ||
| P/B | 3.17 | ||
| P/tB | 3.17 | ||
| EV/EBITDA | 37.45 |
EPS(TTM)0.01
EY0.1%
EPS(NY)0.38
Fwd EY3.68%
FCF(TTM)0.34
FCFY3.31%
OCF(TTM)0.38
OCFY3.65%
SpS2.25
BVpS3.25
TBVpS3.25
PEG (NY)9.89
PEG (5Y)N/A
Graham Number0.86
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.96% | ||
| ROE | 1.04% | ||
| ROCE | 5.06% | ||
| ROIC | 4% | ||
| ROICexc | 16.98% | ||
| ROICexgc | 16.98% | ||
| OM | 7.39% | ||
| PM (TTM) | 1.5% | ||
| GM | 86.29% | ||
| FCFM | 15.12% |
ROA(3y)-120.78%
ROA(5y)-101.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.01%
GM growth 5Y8.9%
F-Score7
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 625.51% | ||
| Cap/Sales | 1.54% | ||
| Interest Coverage | 6.95 | ||
| Cash Conversion | 218.16% | ||
| Profit Quality | 1004.67% | ||
| Current Ratio | 15.06 | ||
| Quick Ratio | 13.71 | ||
| Altman-Z | 19.04 |
F-Score7
WACC8.92%
ROIC/WACC0.45
Cap/Depr(3y)208.01%
Cap/Depr(5y)235.23%
Cap/Sales(3y)4.01%
Cap/Sales(5y)12.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
EPS Next Y104.16%
EPS Next 2Y54.49%
EPS Next 3Y40.77%
EPS Next 5Y30.41%
Revenue 1Y (TTM)251.54%
Revenue growth 3Y118.63%
Revenue growth 5Y88.1%
Sales Q2Q%83.6%
Revenue Next Year135.53%
Revenue Next 2Y81.08%
Revenue Next 3Y61.94%
Revenue Next 5Y43.08%
EBIT growth 1Y121.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year242.65%
EBIT Next 3Y71.85%
EBIT Next 5YN/A
FCF growth 1Y139.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y143.58%
OCF growth 3YN/A
OCF growth 5YN/A
DELCATH SYSTEMS INC / DCTH FAQ
What is the ChartMill fundamental rating of DELCATH SYSTEMS INC (DCTH) stock?
ChartMill assigns a fundamental rating of 6 / 10 to DCTH.
What is the valuation status for DCTH stock?
ChartMill assigns a valuation rating of 4 / 10 to DELCATH SYSTEMS INC (DCTH). This can be considered as Fairly Valued.
What is the profitability of DCTH stock?
DELCATH SYSTEMS INC (DCTH) has a profitability rating of 4 / 10.
Can you provide the financial health for DCTH stock?
The financial health rating of DELCATH SYSTEMS INC (DCTH) is 8 / 10.
What is the expected EPS growth for DELCATH SYSTEMS INC (DCTH) stock?
The Earnings per Share (EPS) of DELCATH SYSTEMS INC (DCTH) is expected to grow by 104.16% in the next year.